Hemealumen TS: Revolutionary Polychromatic Photobiomodulation System

Revolutionary Polychromatic Photobiomodulation System The Hemealumen TS Polychromatic Device is a cutting-edge, minimally invasive photoluminescence blood treatment system designed to combat auto-immune, viral, bacterial, and fungal diseases. It is also effective for treating similar conditions in pets, including dogs and cats. This advanced device enhances patient outcomes by utilizing light-based therapy to stimulate the body's natural healing processes. Immediate Clinical Impact Immediate Impact: Complete resolution of dengue/zika in 48 hours. 55/55 malaria cases resolved in 2 days. Zero COVID-19 mortality with 7-day reduced hospital stays. Proven Safety: Over 80 years of clinical use with >95% success rates across 6,500+ patients. Zero adverse effects reported in 200+ peer-reviewed studies. Revolutionary Technology: Patented TRIVETTE™ design increases blood exposure time by 600% compared to traditional devices, delivering superior therapeutic outcomes through polychromatic wavelength integration. How Hemealumen TS Works: Advanced Polychromatic Precision Patented TRIVETTE™ Triple Quartz Tube Design The revolutionary triple-tube parallel arrangement extends blood exposure time by 600%, ensuring comprehensive pathogen inactivation and optimal cellular activation. This patented design represents the first significant advancement in UVBI technology. Targeted Pulsed Frequencies Proprietary frequency modulation similar to Rife technology ensures precise cellular targeting while maximizing therapeutic efficacy across multiple biological systems. Transform Patient Outcomes Six-Wavelength Polychromatic System UVC 253.